Skip to main content
SpringerLink
Log in

Combined hepatocholangiocarcinoma

Case-series and review of literature

  • Research Article
  • Published:
International Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background and Aim

Combined hepatocholangiocarcinoma (CHCC) is an infrequent primary hepatic malignancy with no clearly defined diagnostic criteria, poorly studied natural history, and no guidelines regarding therapy. In this study we attempted to address this need and review our experience.

Methods and Results

We performed a retrospective review of all CHCC cases at our institute over the last 10 yr. Eight cases were identified; histological and immunohistochemical criteria used for diagnosis were defined. Patients characteristics were: median age 65 yr (range 47–80); five females; risk factors-cholelithiasis (n=4) and cirrhosis due to chronic viral hepatitis B and C (n=1). Abdominal pain (n=6), hepatomegaly (n=4), and elevated CA 19−9>40 U/mL (n=4/5) were frequent. Early TNM stage (I and II) compared with advanced disease (III and IV) correlated with higher overall survival on univariate analyses [37 and 6 mo respectively (p=0.011)]. Median overall survival was significantly higher in patients who underwent potentially curative resection (23 mo, range 4–48+) compared with patients who underwent non-surgical therapies such as transcatheter arterial chemoembolization and chemotherapy (2 mo, range 1–8) (p=0.0357, one-sided exact log-rank test).

Conclusions

Chronic inflammation and cirrhosis may play a role in pathogenesis of CHCC. Surgical resection and early stage at diagnosis predict longer survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Molmenti EP, Marsh JW, Dvorchik I, Oliver JH 3rd, Madariaga J, Iwatsuki S. Hepatobiliary malignancies. Primary hepatic malignant neoplasms. Surg Clin North Am 1999; 79(1):43–57.

    Article  PubMed  CAS  Google Scholar 

  2. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9(2):191–211.

    Article  PubMed  Google Scholar 

  3. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Sem Liver Dis 2004;24(2):115–125.

    Article  Google Scholar 

  4. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40(3):472–477.

    Article  PubMed  Google Scholar 

  5. Wu PC, Lai VC, Fang JW, Gerber MA, Lai CL, Lau JY. Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J Hepatol 1999;31(5):965–966.

    Article  PubMed  CAS  Google Scholar 

  6. Lee CC, Wu CY, Chen JT, Chen GH. Comparing combined hepatocellular cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study. Hepato Gastroenterology 2002;49(48):1487–1490.

    PubMed  Google Scholar 

  7. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jp J Clinical Oncol 2003;33(6):283–287.

    Article  Google Scholar 

  8. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005;189(1):120–125.

    Article  PubMed  Google Scholar 

  9. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002;94(7):2040–2046.

    Article  PubMed  Google Scholar 

  10. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998;13(1):34–40.

    Article  PubMed  CAS  Google Scholar 

  11. National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies). Natl Toxicol Program Tech Rep Ser 2002;(504):1–357.

    Google Scholar 

  12. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 2000;491:1–412.

    Google Scholar 

  13. Johnson JD, Ryan MJ, Toft JD II, Graves SW, et al. Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F(1) mice. J Agric Food Chem 2000;48(8):3620–3632.

    Article  PubMed  CAS  Google Scholar 

  14. Morcos M, Dubois S, Bralet MP, Belghiti J, Degott C, Terris B. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum. Am J Clin Pathol 2001;116(5):738–743.

    Article  PubMed  CAS  Google Scholar 

  15. Zhou H, Fischer HP. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol 1998Jun;22(6):742–748.

    Article  PubMed  CAS  Google Scholar 

  16. Sonakul D, Koompirochana C, Chinda K, Stitnimakarn T. Hepatic carcinoma with opisthorchiasis. Southeast Asian J Trop Med Public Health 1978;9(2):215–219.

    PubMed  CAS  Google Scholar 

  17. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004;40(2):298–304.

    Article  PubMed  CAS  Google Scholar 

  18. Imai Y, Oda H, Arai M, et al. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas. Jp J Cancer Res 1996;87(10):1056–1062.

    CAS  Google Scholar 

  19. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, et al. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 2004;41(2):292–298.

    Article  PubMed  CAS  Google Scholar 

  20. Haratake J, Hashimoto H. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver 1995;15(1):9–15.

    PubMed  CAS  Google Scholar 

  21. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996;11(8):758–764.

    Article  PubMed  CAS  Google Scholar 

  22. Tickoo SK, Zee SY, Obiekwe S, et al. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol 2002;26(8):989–997.

    Article  PubMed  Google Scholar 

  23. Varnholt H, Asayama Y, Aishima S, Taguchi K, Sugimachi K, Tsuneyoshi M. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma. Oncology Reports 2002;9(1):35–41.

    PubMed  CAS  Google Scholar 

  24. Asayama Y, Taguchi Ki K, Aishima Si S, Nishi H, Masuda K, Tsuneyoshi M. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver 2002;22(1):43–50.

    Article  PubMed  CAS  Google Scholar 

  25. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985;55(1):124–135.

    Article  PubMed  CAS  Google Scholar 

  26. Brumm C, Schulze C, Charels K, Morohoshi T, Kloppel G. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Histopathology 1989;14(5):503–513.

    Article  PubMed  CAS  Google Scholar 

  27. Nishie A, Yoshimitsu K, Asayama Y, et al. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings. AJR. Am J Roentgenol 2005;184(4):1157–1162.

    PubMed  Google Scholar 

  28. Santoro E, Sacchi M, Carboni F, Santoro R, Scardamaglia F. Diagnostic and surgical features of Klatskin tumors. Chirurgia Italiana 1999;51(1):1–7.

    PubMed  CAS  Google Scholar 

  29. Liu YX. [Transcatheter chemoembolication combined with hepatectomy for primary hepatic carcinoma. A clinical and pathological study]. [Chinese]. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] 1992:30(6):342–345, 382.

    PubMed  CAS  Google Scholar 

  30. Monden M, Sakon M, Gotoh M, et al. Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol 1992;31 Suppl:S38–44.

    Article  Google Scholar 

  31. Inoue H, Hori A, Satake M, et al. [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin mitomycin C oil suspension (ADMOS)]. [Japanese] Nippon Igaku Hoshasen Gakkai Zasshi-Nippon Acta Radiologica 1992;52(2):155–163.

    CAS  Google Scholar 

  32. Kokudo N, Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004;84(2):643–657.

    Article  PubMed  Google Scholar 

  33. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 1996;149(4):1167–1175.

    PubMed  CAS  Google Scholar 

  34. Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E, Nematollahi M, Pond GR, Zhang J, Moore MJ. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial. J Clin Oncol 2005;23(10):2332–2338.

    Article  PubMed  CAS  Google Scholar 

  35. Shimoyama T, Shimizu T, Miyashita K, et al. [Study of combined hepatocellular and cholangiocarcinoma]. [Japanese]. Gan to Kagaku Ryoho [Jp J Cancer Chemother] 1993;20(2):295–298.

    PubMed  CAS  Google Scholar 

  36. Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, Wong J. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 2003;138(1):86–90.

    Article  PubMed  Google Scholar 

  37. Jeong BJ, Hyun DH, Lee KW, et al. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma]. [Korean] Korean Journal of Gastroenterology/Taehan Sohwagi Hakhoe Chi 2004;43(1):56–60.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, 14263, Buffalo, NY

    Vishal Bhagat, Milind Javle, Aarti Agrawal & Renuka Iyer MD

  2. Department of Surgery, Roswell Park Cancer Institute, Elm and Carlton Streets, 14263, Buffalo, NY

    John F. Gibbs & Boris Kuvshinoff

  3. Department of Pathology, Roswell Park Cancer Institute, Elm and Carlton Streets, 14263, Buffalo, NY

    Enriquetta Nava

  4. Department of Biostatistics, State University at Buffalo, 14214, Buffalo, NY

    Jihnhee Yu

Authors
  1. Vishal Bhagat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milind Javle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jihnhee Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aarti Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John F. Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Boris Kuvshinoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Enriquetta Nava
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Renuka Iyer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renuka Iyer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhagat, V., Javle, M., Yu, J. et al. Combined hepatocholangiocarcinoma. Int J Gastrointest Canc 37, 27–34 (2006). https://doi.org/10.1385/IJGC:37:1:27

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/IJGC:37:1:27

Key Words

Search

Navigation